iRhythm Technologies, Inc. (IRTC)
- Previous Close
111.27 - Open
110.98 - Bid 112.14 x 100
- Ask 112.44 x 100
- Day's Range
109.49 - 112.74 - 52 Week Range
70.24 - 135.80 - Volume
166,434 - Avg. Volume
449,475 - Market Cap (intraday)
3.49B - Beta (5Y Monthly) 1.31
- PE Ratio (TTM)
-- - EPS (TTM)
-4.04 - Earnings Date May 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
139.11
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
www.irhythmtech.comRecent News: IRTC
Performance Overview: IRTC
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IRTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IRTC
Valuation Measures
Market Cap
3.46B
Enterprise Value
3.46B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.89
Price/Book (mrq)
16.48
Enterprise Value/Revenue
7.02
Enterprise Value/EBITDA
-35.71
Financial Highlights
Profitability and Income Statement
Profit Margin
-25.05%
Return on Assets (ttm)
-13.93%
Return on Equity (ttm)
-54.86%
Revenue (ttm)
492.68M
Net Income Avi to Common (ttm)
-123.41M
Diluted EPS (ttm)
-4.04
Balance Sheet and Cash Flow
Total Cash (mrq)
133.76M
Total Debt/Equity (mrq)
61.79%
Levered Free Cash Flow (ttm)
-10.02M